Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. GlaxoSmithKline plc
  6. News
  7. Summary
    GSK   GB0009252882

GLAXOSMITHKLINE PLC

(GSK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

GlaxoSmithKline : Seeks Approval for Measles, Mumps, Rubella Vaccine in US

08/02/2021 | 03:07pm EDT


ę MT Newswires 2021
All news about GLAXOSMITHKLINE PLC
08:34aSanofi drops vaccine bid amid rivals' success
RE
08:13aSanofi ditches mRNA COVID-19 vaccine after rivals' success
RE
07:44aGLAXOSMITHKLINE : ViiV Healthcare's New Drug Application for HIV Prevention Gets FDA Accep..
MT
07:15aGLAXOSMITHKLINE : ViiV Healthcare Enters Into Exclusive Agreement With Shionogi for Potent..
MT
06:12aGLAXOSMITHKLINE : FDA grants Priority Review to ViiV Healthcare's New Drug Application for..
PU
05:57aViiV Gets FDA Priority Review for Cabotegravir Long-Acting for HIV Prevention
DJ
04:41aSANOFI : Abandons mRNA COVID-19 Jab To Focus On Flu, Other Diseases
MT
03:51aSANOFI : Says Its COVID-19 Vaccine Candidate Demonstrates High Seroconversion in Phase 1/2..
MT
02:57aSanofi to Halt MRNA Covid-19 Vaccine Development Despite Positive Trial Results -- Upda..
DJ
02:27aSANOFI : mRNA COVID-19 Jab Candidate Shows Positive Results in Phase 1/2 Study
MT
More news
Analyst Recommendations on GLAXOSMITHKLINE PLC
More recommendations
Financials
Sales 2021 33 307 M 45 150 M 45 150 M
Net income 2021 3 857 M 5 228 M 5 228 M
Net Debt 2021 20 885 M 28 312 M 28 312 M
P/E ratio 2021 18,2x
Yield 2021 5,77%
Capitalization 69 428 M 95 179 M 94 117 M
EV / Sales 2021 2,71x
EV / Sales 2022 2,53x
Nbr of Employees 94 066
Free-Float 92,2%
Chart GLAXOSMITHKLINE PLC
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PLC
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 1 387,20 GBX
Average target price 1 604,94 GBX
Spread / Average Target 15,7%
EPS Revisions
Managers and Directors
Emma N. Walmsley Chief Executive Officer & Executive Director
Iain James Mackay Chief Financial Officer & Executive Director
Jonathan Richard Symonds Non-Executive Chairman
Karenann K. Terrell Chief Digital & Technology Officer
Hal V. Barron Executive Director & Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
GLAXOSMITHKLINE PLC3.37%95 179
JOHNSON & JOHNSON3.68%429 542
ROCHE HOLDING AG9.24%319 352
PFIZER, INC.19.37%244 283
NOVO NORDISK A/S48.08%227 557
ELI LILLY AND COMPANY34.09%205 250